Gut microbes may contribute to autoimmune kidney disease

The findings of a recent study reveal how gut bacteria modify immune molecules in ways that lead to the development of IgA nephropathy.

Industrial societies may be losing gut microbes that help digest plants

The findings of a recent study suggest that Ruminococcus bacteria were more prevalent in ancient human populations and non-industrialized societies, likely due to the high dietary fiber intake.

6th Skin Microbiome & Cosmeceuticals Congress – Report

The report summarizes numerous presentations on the skin microbiome, covering topics such as acne, anti-aging, atopic dermatitis, and "microbiome-friendly" cosmetics.

Gut microbiota may shape a newborn’s immune system through serotonin production

The findings of a recent study suggest that the infant microbiota produces neurotransmitters that are required for the development of the immune system.

The interplay of diet and the microbiota may influence gut inflammation

The results of a recent study suggest that certain dietary changes can counteract bacterial functions that promote disease. The findings thus underscore the importance of examining microbial functions to understand…

Seed Health introduces revolutionary vaginal microbiome product: VS-01

The product, based on the pioneering research of Dr. Jacques Ravel, is the first of its kind to be clinically validated for establishing an optimal vaginal microbiome, dominated by Lactobacillus…

SynBalance Srl secures dual honors at 2024 NutraIngredients Awards

The company was honored with the Ingredient of the Year award in the Microbiome Modulation and the Beauty from Within category.

Microbial signature linked to improved response to immunotherapy in older people

The findings of a recent study highlight the importance of considering age-related immune changes and gut microbiota composition for developing personalized immunotherapy approaches.

Microbial metabolites promote colon cancer by suppressing anti-tumor responses

A recent study demonstrated causation between microbial DCA metabolism and anti-tumor CD8+ T cell response in colorectal cancer.

Biompharma’s Bi104 Receives FDA Orphan Drug Designation for Angelman Syndrome Treatment

Bi104 is a microbiome-modifying biologic designed to diversify and modulate the gut microflora and metabolite profile.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top